} clin oncol markman m intraperitoneal antineoplastic drug delivery rationale and results lancet oncol markman m intraperitoneal hyperthermic chemotherapy as treatment of peritoneal carcinomatosis trihexyphenidyl watson pharma of colorectal cancer j clin oncol author reply conti different name lasix m, trihexyphenidyl watson pharma de giorgi u, tazzari v, bezzi f and baccini trihexyphenidyl watson pharma � clinical pharmacology of intraperitoneal cisplatinbased chemotherapy j chemother trihexyphenidyl watson pharma suppl parker rj, hartman kd and sieber sm lymphatic absorption and tissue disposition of liposomeentrapped [c]adriamycin following intraperitoneal administration to rats cancer res parker rj, priester er and sieber sm comparison trihexyphenidyl watson pharma of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposomeentrapped trihexyphenidyl watson pharma [c]cytosine betadarabinofuranoside following intraperitoneal administration to rats drug metab dispos rosa p and clementi f absorption and tissue distribution of doxorubicin entrapped in liposomes different name lasix following intravenous or trihexyphenidyl watson pharma intraperitoneal administration pharmacology morice p et al are nodal metastases in ovarian cancer chemoresistant lesions?